Possible New Therapy Against Colon Cancer
Some colon cancers can be harder to fight than others. New therapies are being investigated in the hopes of yielding better results for patients with these aggressive colon cancers.
Experimental Rx Helped Lung Cancer Patients Live for Years
Lung cancer is the leading cause of cancer-related death in the US. Advanced lung cancers have spread to other areas of the body and are extremely tough to beat. An experimental therapy may be a game changer.
Cancer Clinical Trial Becomes Futile
Sometimes clinical trials have to be stopped because the therapy being tested does more harm than good. This is what happened in recent esophageal cancer study.
More Months of Life with Colorectal Cancer
Once cancer has spread to another organ, treatment options become more limited. In a good news story, researchers may have found a way to help folks whose advanced colorectal cancer has spread to the liver.
Targeted Cancer Therapy Casts Wider Net
Targeting cancer gene mutations has been changing the way non-small cell lung cancer ( NSCLC ) is treated. As scientists learn more about the genetic makeup of tumors, more personalized therapy has become available.
Putting the Screws to Resistant Tumors
Cancer is one masterful disease process. Why? It's a master at finding its way around obstacles like treatment drugs. That's why it may take a combination approach to put the screws to some cancers.
FDA approves Erbitux to treat late-stage head and neck cancer
The U.S. Food and Drug Administration today approved Erbitux ( cetuximab ) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.